DAIC

MARCH 14, 2025

tim.hodson Fri, 03/14/2025 - 11:42 March 11, 2025 CareDx, Inc. Simultaneous pancreas-kidney (SPK) transplants are known to improve the quality of life and long-term survival of patients with insulin dependent diabetes and advanced renal disease. 5 As with other organ transplants, the organs are at risk of rejection.

Heart Transplant 87

Heart Transplant Transplant Pediatrics Quality of Life 87

HCPLive

APRIL 1, 2025

Our Q1 2025 recap for endocrinology spotlights 5 regulatory updates, 5 key trial announcements, and top expert perspectives in diabetes care.

Diabetes 52

Diabetes 52

HCPLive

APRIL 1, 2025

The first quarter of 2025 saw approvals in diabetes, depression, kidney disease, and pain, among others. Read more about high-impact approvals of Q1 now.

Kidney Disease 52

Kidney Disease Diabetes 52

DAIC

MARCH 11, 2025

tim.hodson Tue, 03/11/2025 - 11:19 Mar. 10, 2025-- Corcept Therapeutics Inc., Momentums design is similar to Corcepts CATALYST clinical trial, which demonstrated that one in four patients with difficult-to-control type 2 diabetes has hypercortisolism. Patients with a dexamethasone suppression test (DST) value greater than 1.8

Hypertension 82

Hypertension Blood Pressure Public Health Cardiovascular Disease 82

American Heart News - Heart News

FEBRUARY 18, 2025

18, 2025 About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, kidney disease, type 2 diabetes and obesity.[1] DALLAS, Feb. 1] This cluster of chronic health conditions is called.

Kidney Disease 118

Kidney Disease Obesity Heart Disease Diabetes 118

American Heart News - Heart News

APRIL 1, 2025

DALLAS, April 1, 2025 A New York City-based physician scientist who explores ways to improve health by looking at the ways in which cells and molecules impact disease and an epidemiologist from Baltimore who has devoted her career to identifying ways.

Research 69

Research Diabetes 69

DAIC

MARCH 25, 2025

tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

Cardiometabolic Health Congress

OCTOBER 10, 2024

This exciting overview highlights the top 10 AI-powered cardiometabolic startups poised to make significant impacts in 2025. Vitadio : Digital therapeutics for type 2 diabetes and prediabetes, expanding globally. LumineticsCore : An AI diagnostics company with FDA-cleared systems for detecting diabetic retinopathy.

Innovation 52

Innovation Technology Kidney Disease Chronic Disease 52

DAIC

FEBRUARY 14, 2025

Lorraine and Bill Dodero tim.hodson Fri, 02/14/2025 - 15:33 Feb. 10, 2025 A generous gift of $5 million from Lorraine and Bill Dodero will establish the Lorraine and Bill Dodero Limb Preservation Center at University Hospitals Harrington Heart & Vascular Institute in Cleveland, Ohio.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Cancer Innovation Best Practices 52

HCPLive

FEBRUARY 14, 2025

On February 14, 2025, the FDA approved the first rapid-acting biosimilar insulin product called nsulin-aspart-szjj (Merilog).

Diabetes 59

Diabetes 59

HCPLive

OCTOBER 21, 2024

Novo Nordisk will present more detailed data in 2025 and plans to file for an expanded label for Rybelsus for this population.

Diabetes 59

Diabetes 59

DAIC

FEBRUARY 4, 2025

tim.hodson Tue, 02/04/2025 - 17:13 Feb. 3, 2025 Today, Peripheral Artery Disease (PAD)affects 10 million Americans and is the most common cause of limb amputation outside of trauma. If you have a history of diabetes, high blood pressure, or tobacco use, you should talk to your doctor about being screened for PAD. What Is PAD?

Peripheral Arterial Disease 52

Peripheral Arterial Disease Blood Pressure Risk Factors Diabetes 52

Circulation

MARCH 9, 2025

Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025. Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors.

Kidney Disease 83

Kidney Disease Biomarkers Heart Failure Risk Factors 83

Circulation

FEBRUARY 16, 2025

Circulation, Volume 151, Issue 7 , Page 508-510, February 18, 2025.

Diabetes 45

Diabetes Hypertension Circulation 45

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP361-ATP361, February 1, 2025. Introduction:Stroke is a leading cause of death and disability worldwide, with diabetes being a significant risk factor that exacerbates stroke outcomes.

Diabetes 40

Diabetes Stroke Strokes Risk Factors 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP158-ATP158, February 1, 2025. Background:Research suggests that the absolute number of strokes among people with diabetes is increasing as the population with diabetes grows. In response to a finding from the 2021 Joint Commission survey for not addressing an HbA1c=9.3,

Diabetes 40

Diabetes Stroke Strokes Inpatient 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP31-ATP31, February 1, 2025. Diabetes increases the risk of Vascular Contributions to Cognitive Impairment&Dementia (VCID) and stroke further amplifies this effect. Diabetes also dysregulates the Endothelin (ET) system.

Diabetes 40

Diabetes Dementia Strokes Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP48-AWP48, February 1, 2025. Introduction:Type-2 diabetes increases the risk of stroke; however, the mechanisms remain incompletely understood. Treatment with sEHI reduced vascular amylin deposition (198.6

Diabetes 40

Diabetes Strokes Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP116-ATMP116, February 1, 2025. Background and Purpose:Gut microbiota dysfunction is associated with diabetic cognitive impairment (DCI). However, the mechanisms underlying the interaction of gut microbiota dysbiosis and DCI remain poorly understood.

Diabetes 40

Diabetes Thrombosis Strokes Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP289-AWP289, February 1, 2025. Background:The ABCD-GENE score, incorporating age, body mass index, chronic kidney disease, diabetes, and CYP2C19 genotypes, is a validated risk score that integrates clinical risk factors with genetic information to predict clopidogrel response. years, with 65.0%

Diabetes 40

Diabetes Strokes Stroke Myocardial Infarction 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP392-ATP392, February 1, 2025. Diabetes is a widespread disease, and stroke is one of the serious complications of diabetes. Antidiabetic therapy increases the risk of recurrent hypoglycemia (RH). However, the total duration for which these perfusion deficits last is unknown.

Diabetes 40

Diabetes Ischemia Strokes Stroke 40

Circulation

JANUARY 20, 2025

Circulation, Volume 151, Issue 3 , Page 199-201, January 21, 2025.

Heart Failure 45

Heart Failure Diabetes Circulation 45

The American Journal of Cardiology

MARCH 7, 2025

Publication date: Available online 7 March 2025 Source: The American Journal of Cardiology Author(s): Yong-Hoon Yoon, Tae oh Kim, Gyung-Min Park, Jong-Young Lee, Jae-Hyung Roh, Jae-Hwan Lee, Kyusup Lee, Pil Hyung Lee, Jaewon Choe, Young-Hak Kim, Seung-Whan Lee

Diabetes 40

Diabetes 40

The American Journal of Cardiology

MARCH 8, 2025

Publication date: Available online 7 March 2025 Source: The American Journal of Cardiology Author(s): George G. Kidess, Mohammad Hamza, Rohit Goru, Jawad Basit, Mowaffak Alraiyes, M Chadi Alraies

Atrial Fibrillation 40

Atrial Fibrillation Diabetes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP43-ATP43, February 1, 2025. Since diabetes increases VCID risk, our first goal was to develop a multi-etiology model of VCID in diabetes. ETARs, hypoxia marker HIF1, and senescence marker p21 levels were increased in the UCCAO+ME diabetic group; while ETBRs rather decreased.

Dementia 40

Dementia Diabetes Strokes Stroke 40

DAIC

APRIL 2, 2025

Stone, MD Mount Sinai Health System tim.hodson Wed, 04/02/2025 - 15:26 March 31, 2025 Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than conventional angiography, the more commonly used technique.

Stents 40

Stents Stent Outcomes Coronary Angiogram 40

DAIC

JULY 23, 2024

Haechan Cho, MD received Best Abstract first runner-up after presenting his abstract, “Coronary Computed Tomography Angiography Versus Functional Testing In Patients With Diabetes And Suspected Coronary Artery Disease: Real-world Evidence From The Nationwide Cohort.” and the Ma Family, who provided a $5,000 case prize for the winner.

Chest Pain 105

Chest Pain Coronary Artery Disease Plaque Ischemia 105

Circulation

JANUARY 20, 2025

Circulation, Volume 151, Issue 3 , Page e30-e30, January 21, 2025.

Diabetes 45

Diabetes Circulation 45

The American Journal of Cardiology

FEBRUARY 5, 2025

Publication date: Available online 3 February 2025 Source: The American Journal of Cardiology Author(s): Giuseppe Tavilla, Md Anamul Islam, Amber Malhotra, Daniel Lincoln Beckles

Diabetes 40

Diabetes 40

The American Journal of Cardiology

MARCH 18, 2025

Publication date: Available online 17 March 2025 Source: The American Journal of Cardiology Author(s): Muhammad Hanif, Allison G. Hays, Jai S. Nagarajan, Shiva P. Sah, Ruth S. Weinstock, Cynthia C.

Diabetes 40

Diabetes 40

DAIC

MARCH 25, 2025

tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across t he KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Cardiometabolic Health Congress

NOVEMBER 25, 2024

On-demand access is available now and will remain open until December 2025. Diabetes Management: Gain insights into precision medicine, advanced insulin therapies, and continuous glucose monitoring (CGM) for cardiovascular risk assessment. When Will It Be Available?

CME 52

CME Obesity Certification Education 52

The American Journal of Cardiology

JANUARY 12, 2025

Publication date: Available online 11 January 2025 Source: The American Journal of Cardiology Author(s): Annunziata Nusca, Maria Pia Di Bitonto, Agostino Span, Bernardini Federico, Fabio Mangiacapra, Elisabetta Ricottini, Rosetta Melfi, Sara Giannone, Gian Paolo Ussia, Francesco Grigioni

Diabetes 40

Diabetes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP9-ATP9, February 1, 2025. Hemorrhagic transformation (HT), a complication of IVT, is more frequent in acute hyperglycemia and diabetes (DM) and is associated with poor clinical outcomes.

Hemorrhage 40

Hemorrhage Diabetes Strokes Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP350-ATP350, February 1, 2025. Type 2 diabetes mellitus (T2DM) induces chronic inflammation, which can worsen the secondary injury following ischemic stroke.

Stroke 40

Stroke Strokes Diabetes Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP56-AWP56, February 1, 2025. The association remained significant after adjustment for age, race, gender, hypertension, diabetes, smoking status, education level and regular dental care use (Adjusted OR 0.61 However, the impact of preventative oral behavior such as dental flossing is unknown.

Atherosclerosis 75

Atherosclerosis Stenosis Risk Factors Education 75

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A51-A51, February 1, 2025. Background:Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown a reduction in major adverse cardiovascular events (MACE) among patients with type 2 diabetes mellitus (T2DM).

Heart Failure 40

Heart Failure Obesity Stroke Strokes 40